These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19803878)

  • 21. Proteomic analysis of colorectal cancer: discovering novel biomarkers.
    Skandarajah AR; Moritz RL; Tjandra JJ; Simpson RJ
    Expert Rev Proteomics; 2005 Oct; 2(5):681-92. PubMed ID: 16209648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
    Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
    Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and detection of ovarian cancer.
    Breedlove G; Busenhart C
    J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.
    Kobayashi E; Ueda Y; Matsuzaki S; Yokoyama T; Kimura T; Yoshino K; Fujita M; Kimura T; Enomoto T
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1902-12. PubMed ID: 22962405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass spectrometry: uncovering the cancer proteome for diagnostics.
    van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
    Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomics for the identification of new prostate cancer biomarkers.
    Ornstein DK; Tyson DR
    Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of proteomics in ovarian cancer: which sample should be used?
    Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
    Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
    Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
    Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins.
    Li B; An HJ; Kirmiz C; Lebrilla CB; Lam KS; Miyamoto S
    J Proteome Res; 2008 Sep; 7(9):3776-88. PubMed ID: 18642944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and monitoring of ovarian cancer.
    Su Z; Graybill WS; Zhu Y
    Clin Chim Acta; 2013 Jan; 415():341-5. PubMed ID: 23165217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
    Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
    Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian cancer: biomarker proteomic diagnosis in progress.
    Zhang Y; Guo B; Bi R
    Appl Biochem Biotechnol; 2012 Oct; 168(4):910-6. PubMed ID: 22945560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics to diagnose human tumors and provide prognostic information.
    Ornstein DK; Petricoin EF
    Oncology (Williston Park); 2004 Apr; 18(4):521-9; discussion 529-32. PubMed ID: 15134357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum proteomics using mass spectrometry.
    Hood BL; Malehorn DE; Conrads TP; Bigbee WL
    Methods Mol Biol; 2009; 520():107-28. PubMed ID: 19381950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple biomarker panels for early detection of ovarian cancer.
    Yurkovetsky ZR; Linkov FY; E Malehorn D; Lokshin AE
    Future Oncol; 2006 Dec; 2(6):733-41. PubMed ID: 17155900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis of frozen tissue samples using laser capture microdissection.
    Mukherjee S; Rodriguez-Canales J; Hanson J; Emmert-Buck MR; Tangrea MA; Prieto DA; Blonder J; Johann DJ
    Methods Mol Biol; 2013; 1002():71-83. PubMed ID: 23625395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum proteomics for gastric cancer.
    Liu W; Yang Q; Liu B; Zhu Z
    Clin Chim Acta; 2014 Apr; 431():179-84. PubMed ID: 24525212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.